TCAs versus placebo - National Center for Biotechnology Information

More documents

Recommendations

Info

SCHIFANO1990 Schifano, F., Garbin, A., Renesto, V., De, D., Trinciarelli, G., Silvestri, A. et al. (1990). A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people. Acta Psychiatrica Scandinavica, 81, 289-294. SCHILDKRAUT1964 (Published Data Only) Schildkraut, J. J., Klerman, G. L., Hammond, R., & Friend, D. G. (1964). Excretion of 3-methoxy-4-hydroxymandelic acid (VMA) in depressed patients treated with antidepressant drugs. Journal of Psychiatric Research, 2, 266. SCHILDKRAUT1965 Schildkraut, J. J., Gordon, E. K., & Durell, J. (1965). Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. Journal of Psychiatric Research, 3, 213-228. SCHULTERBRANDT1974 (Published Data Only) Schulterbrandt, J.G., Raskin, A., & Reatig, N. (1974). True and apparent side effects in a controlled trial of Chlorpromazine and Imipramine in Depression. Psychopharmacologia, 38, 303-317. SHALAL1996 Shalal, B., Piel, E., Mecz, L., Kremer, I., & Klein, E. (1996). Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression - a double-blind controlled study. Biological Psychiatry, 40, 1181-1183. SHAMMAS1977 (Published Data Only) Shammas, E. (1977). Controlled comparison of bromazepam, amitriptyline, and placebo in anxiety-depressive neurosis. Diseases of the Nervous System, 38, 201-207. SHAPIRA1989 (Published Data Only) Shapira, B., Reiss, A., Kaiser, N., Kindler, S., & Lerer, B. (1989). Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients. Journal of Affective Disorders, 16, 1-4. SHAPIRA1992 Shapira, B., Yagmur, M. J., Gropp, C., Newman, M., & Lerer, B. (1992). Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression. Biological Psychiatry, 31, 975-983. SHAPIRA1993 Shapira, B., Cohen, J., Newman, M. E., & Lerer, B. (1993). Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients. Biological Psychiatry, 33, 531-535. SHARMA1980 Sharma, S. & Hegde, R. (1980). Therapeutic efficacy of doxepin in divided and single dose regime. Indian Journal of Psychiatry, 22, 283-287. SHEA1992A (Published Data Only) Shea, M. T., Elkin, I., Imber, S. D., Sotsky, S. M., Watkins, J. T., Collins, J. F. et al. (1992). Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Archives of General Psychiatry, 49, 782-787. SHELTON1997 (Published Data Only) Shelton, R. C., Davidson, J., Yonkers, K. A., Koran, L., Thase, M. E., Pearlstein, T. et al. (1997). The undertreatment of dysthymia. Journal of Clinical Psychiatry, 58, 59-65. SHEPHERD1981 (Published Data Only) Shepherd, M. (1981). Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a controlled clinical trial. Psychological Medicine, 11, 409-416. SHERWOOD1993 Sherwood, N. & Hindmarch, I. (1993). A comparison of five commonly prescribed antidepressants with particular reference to their behavioural toxicity. Human Psychopharmacology, 8, 417-422. SHIPLEY1981 (Published Data Only) Shipley, J. E., Kupfer, D. J., Spiker, D. G., Shaw, D. H., Coble, P. A., Neil, J. F. et al. (1981). Neuropsychological assessment and EEG sleep in affective disorders. Biological Psychiatry, 16, 907-918. SHOPSIN1971 (Published Data Only) Shopsin, B. & Gershon, S. (1971). Plasma cortisol response to dexamethasone suppression in depressed and control patients. Archives of General Psychiatry, 24, 320-326. SIRIS1982 Siris, S. G., Rifkin, A. E., & Reardon, G. T. (1982). Response of postpsychotic depression to adjunctive imipramine or amitriptyline. Journal of Clinical Psychiatry, 43, 485-486. 89
SIRIS1987A (Published Data Only) Siris, S. G., Morgan, V., Fagerstrom, R., Rifkin, A., & Cooper, T. B. (1987). Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. Archives of General Psychiatry, 44, 533-539. SIRIS1988A (Published Data Only) Siris, S. G., Adan, F., Cohen, M., Mandeli, J., Aronson, A., & Casey, E. (1988). Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. American Journal of Psychiatry, 145, 1532-1537. SIRIS2001A Siris, S. G., Rifkin, A. E., Reardon, G. T., & November, M. (2001). Comparison of imipramine and benztropine in the prevention of extrapyramidal side effects of fluphenazine. Psychopharmacology Bulletin, . SJOQVIST1971 Sjoqvist, F. (1971). A pharmacokinetic approach to the treatment of depression. International Pharmacopsychiatry, 6, 147-169. SOLOFF1989 (Published Data Only) Soloff, P. H., George, A., Nathan, S., Schulz, P. M., Cornelius, J. R., Herring, J. et al. (1989). Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. Journal of Clinical Psychopharmacology, 9, 238-246. SPIKER1988 (Published Data Only) Spiker, D. G. & Kupfer, D. J. (1988). Placebo response rates in psychotic and nonpsychotic depression. Journal of Affective Disorders, 14, 21-23. STANER1993 (Published Data Only) Staner, L. & Mendlewicz, J. (1993). Efficacy of tianeptine in the treatment of major depression and depressed bipolar disorders. Illustration of the interest of surveillance of a European multicentre double-blind study in progress: Tianeptine versus placebo and imipramine. European Psychiatry, 8, 11S-15S. STEINBOOK1979 (Published Data Only) Steinbook, R. M., Jacobson, A. F., Weiss, B. L., & Goldstein, B. J. (1979). Amoxapine, imipramine and placebo: A double-blind study with pretherapy urinary 3-methoxy-4-hydroxyphenylglycol levels. Current Therapeutic Research, Clinical & Experimental, 26. STEWART1988 (Published Data Only) Stewart, J. W., Quitkin, F. M., McGrath, P. J., Rabkin, J. G., Markowitz, J. S., Tricamo, E. et al. (1988). Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment. Psychiatry Research, 25, 213-222. STEWART1988A (Published Data Only) Stewart, J. W., Harrison, W., Cooper, T. B., & Quitkin, F. M. (1988). Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity. Psychiatry Research, 25, 195-201. STEWART1989 (Published Data Only) Stewart, J. W., McGrath, P. J., Quitkin, F. M., Harrison, W., Markowitz, J., Wager, S. et al. (1989). Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo. Archives of General Psychiatry, 46, 1080-1087. STEWART1989A (Published Data Only) Stewart, J. W. & Halbreich, U. (1989). Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication. Biological Psychiatry, 25, 33-38. STEWART1992 (Published Data Only) Stewart, J. W., McGrath, P. J., & Quitkin, F. M. (1992). Can mildly depressed outpatients with atypical depression benefit from antidepressants? American Journal of Psychiatry, 149, 615-619. STEWART1993 (Published Data Only) Stewart, J. W., McGrath, P. J., Quitkin, F. M., Rabkin, J. G., Harrison, W., Wager, S. et al. (1993). Chronic depression: response to placebo, imipramine, and phenelzine. Journal of Clinical Psychopharmacology, 13, 391-396. STEWART1993A (Published Data Only) Stewart, J. W., Mercier, M. A., Agosti, V., Guardino, M., & Quitkin, F. M. (1993). Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients. Journal of Clinical Psychopharmacology, 13, 114-119. STEWART1997 (Published Data Only) Stewart, J. W., Tricamo, E., McGrath, P. J., & Quitkin, F. M. (1997). Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. American Journal of Psychiatry, 154, 31-36. 90
Page 1 and 2:
Comparisons Included in this Clinic
Page 3 and 4:
MERIDETH1983 NANDI1976 NORTON1984 P
Page 5 and 6:
out in the first week. BEASLEY1991B
Page 7 and 8:
Study Type: RCT Study Description:
Page 9 and 10:
Page 11 and 12:
criteria either at screening or at
Page 13 and 14:
FEIGHNER1979 Study Type: RCT Study
Page 15 and 16:
Page 17 and 18:
Info on Screening Process: 765 part
Page 19 and 20:
Blindness: Double blind Duration (d
Page 21 and 22:
ITIL1983A Study Type: RCT Study Des
Page 23 and 24: Study Type: RCT Study Description:
Page 27 and 28: Setting: Outpatients; US. Notes: 10
Page 29 and 30: Blindness: Double blind Duration (d
Page 31 and 32: RAMPELLO1991 Study Type: RCT Study
Page 33 and 34: unavailable for follow-up. known to
Page 35 and 36: Blindness: Double blind Duration (d
Page 39 and 40: episode. Baseline: Amitriptyline Mi
Page 41 and 42: DEBUS1980 Healthy participants DECA
Page 43 and 44: JOHNSTONE1980A Neurotic illness = n
Page 45 and 46: MULSANT2001B Irrelevant comparison
Page 47 and 48: ROTHBLUM1982 Combination therapy RO
Page 49 and 50: BEASLEY1991B (Published Data Only)
Page 51 and 52: FEIGHNER1989B (Published Data Only)
Page 53 and 54: LYDIARD1989 (Published Data Only) L
Page 55 and 56: SHRIVASTAVA1992 (Published Data Onl
Page 57 and 58: BALESTRIERI2004 Balestrieri, M., Ca
Page 59 and 60: CHANG2005 Chang, F. (2005). Strateg
Page 61 and 62: FINK1965 (Published Data Only) Fink
Page 63 and 64: HARRISON1986 (Published Data Only)
Page 65 and 66: KELLER1993 Keller, M. B., Lavori, P
Page 67 and 68: LEE1993 Lee, J. H., Reynolds, C. F.
Page 69 and 70: MULSANT2001B Mulsant, B. H., Sweet,
Page 71 and 72: PRESKORN1983 (Published Data Only)
Page 73: RICKELS1964 (Published Data Only) R
Page 77: VERSIANI1990A (Published Data Only)
show all

TCAs versus placebo - National Center for Biotechnology Information

Create successful ePaper yourself

Delete template?

Save as template?